Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 18, 2024Frontiers in ImmunologyOpen Access

Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study

View Full Paper
Ask AI
Bookmark
Share

Authors

SZShuangjing ZhuYLYunzhi LinZDZhen Ding

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhu et al. (2024) studied this question.

synapsesocial.com/papers/68e6e99bb6db6435876645eahttps://doi.org/10.3389/fimmu.2024.1352712
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identifying Potential Drug Targets for the Treatment of Ulcerative Colitis Using Mendelian Randomization Combined with Co-localization Analysis2024 · 1 citations
  2. 2Decoding the Molecular Landscape of Inflammatory Bowel Disease: A Mendelian Randomization and Machine Learning Analysis2025 · 1 citations
  3. 3Evaluating the causal effect of circulating proteome on the risk of inflammatory bowel disease-related traits using Mendelian randomization2024 · 1 citations
  4. 4Association between 23 drugs and inflammatory bowel disease: a two-sample Mendelian randomization study2024 · 1 citations
  5. 5Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation2024 · 4 citations